Dr. Leila Rezakhani | tissue egineering | Excellence in Innovation

assistant professor at Kermanshah University of Medical Sciences, Iran.

Leila Rezakhani is an Assistant Professor in the Department of Tissue Engineering at Kermanshah University of Medical Sciences. With a Ph.D. in Tissue Engineering, she has extensive research experience in scaffolds, exosome-based therapies, and 3D cancer modeling. Her research focuses on the therapeutic applications of decellularized tissues and natural compounds in cancer treatment. Leila has demonstrated a strong academic and research background, supported by numerous research projects and publications.

profile

Google scholar

Scopus Profile

Education 🎓

Dr. Leila Rezakhani completed her B.Sc. in Anesthesia Nursing from Kermanshah University of Medical Sciences in 2011, followed by an M.Sc. in Anatomical Sciences from the same university in 2013. During her master’s studies, she focused on the impact of natural compounds on breast and prostate cancer cell lines, an area that laid the foundation for her future research in cancer therapies. In 2020, she earned her Ph.D. in Tissue Engineering from Shahrekord University of Medical Sciences. Her doctoral research centered on the chitosan-based delivery of crab extracellular vesicles into 3D-simulated breast cancer models, reflecting her interest in innovative therapeutic solutions for cancer. Throughout her academic journey, Dr. Rezakhani was recognized as one of the top students at both undergraduate and graduate levels, earning accolades for her exceptional academic performance and research capabilities.

Experience 🧑‍🔬

Dr. Rezakhani has accumulated extensive experience in both academic and research fields. She currently serves as an Assistant Professor at Kermanshah University of Medical Sciences, where she applies her expertise in tissue engineering and cancer research. Over the years, Dr. Rezakhani has honed her skills in laboratory techniques, such as cell culture, exosome isolation, scaffold fabrication, and 3D modeling for cancer research. She has led multiple research projects focusing on the therapeutic application of decellularized tissues, exosomes, and scaffolds. Additionally, her hands-on experience extends to the development of 3D bioprinting methods and exosome-based drug delivery systems. Her career has been marked by a commitment to bridging the gap between research and clinical treatments, with a particular focus on regenerative medicine and cancer therapies.

Research Interests 🔬

Dr. Leila Rezakhani’s research focuses on tissue engineering, cancer biology, and regenerative medicine. She is particularly interested in the therapeutic application of decellularized tissues and scaffolds in clinical treatments, aiming to enhance tissue regeneration and healing. Her work in 3D cancer modeling has provided valuable insights into the behavior of cancer cells and has facilitated the development of new drug delivery systems, including the use of exosomes for targeted cancer therapy. Dr. Rezakhani also explores the potential of 3D bioprinting in creating functional tissue models and organ parts, which could revolutionize regenerative medicine. Her research has significant implications for the treatment of various diseases, including cancer and tissue degeneration, and she is continuously working on innovative strategies to improve the efficiency of tissue-engineered scaffolds and exosome-based therapies for clinical applications.

Awards 🏆

Throughout her academic and professional career, Dr. Leila Rezakhani has been recognized for her excellence in research and academics. She was a top student in both her undergraduate and graduate courses, reflecting her dedication and academic prowess. Dr. Rezakhani’s contributions to tissue engineering and regenerative medicine have earned her several accolades, including recognition for her innovative work on decellularized tissues and exosome-based therapies. Her Ph.D. research, which focused on the use of chitosan-based delivery systems for cancer treatment, garnered praise for its innovative approach. Additionally, Dr. Rezakhani has been acknowledged for her significant contributions to cancer research, specifically in the development of novel therapeutic strategies using exosomes and 3D modeling. Her awards and honors reflect her standing as a leading researcher in her field, making her a highly respected figure in tissue engineering and regenerative medicine.

Conclusion 🎯